WESTWOOD, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”), a leading global medical technology company committed to remarkable service, trusted performance and outstanding value, has been awarded the respected Global Excellence Award for "Most Innovative Wound Closure Products Manufacturer - 2024 USA" by Global Health & Pharma Magazine (GPH). This recognition highlights the company’s commitment to excellence in providing high-performance technologies and solutions that enhance surgical outcomes.

“This award reflects our dedication to developing advanced wound closure solutions that improve patient outcomes and elevate surgical care,” said Tom Testa, Corza Medical CEO. “At Corza Medical, we pride ourselves on putting the needs of our customer and their patients first—while anticipating their needs by prioritizing world-class product quality, customer service and innovation.”

Established in 2020, the Global Excellence Awards celebrate organizations that set the highest standards and drive innovation in the health and pharmaceutical sectors. Each nominee undergoes a rigorous assessment process conducted by an in-house research team. The team evaluates candidates independently, examining a comprehensive array of publicly available sources, including news articles, journals, corporate websites, professional directories and press releases.

The selection criteria consider industry experience, previous accolades, digital and physical presence, client and investor reviews and corporate progression. This meticulous vetting process ensures that only the most deserving organizations are recognized for their significant contributions to healthcare.

Corza Medical joins a distinguished group of companies acknowledged for their innovative approaches and impact on the healthcare landscape. The Global Excellence Awards shine a spotlight on organizations that continuously push the boundaries of what is possible in healthcare and medicine.

To learn more about how Corza Medical is leading innovation in the wound closure space, visit the expanded award coverage in Global Health & Pharma Magazine here.

About Corza Medical
Corza Medical is a leading global medical technology company that specializes in innovative surgical solutions and technologies. With a global team of approximately 3,000 employees supporting clinicians, distributor-partners and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with many industry-leading brands, including Quill^® barbed sutures, Sharpoint^® Plus and Look™ surgical sutures, Katena^® reusable and Blink™ single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint^® microsurgical knives and the TachoSil^® fibrin sealant patch. For more information, please visit www.corza.com.

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Tags

More Like This

Corza Medical Named “Best Overall MedTech Company” in 8th Annual MedTech Breakthrough Awards Program

Corza Medical Named to the 2024 MedTech Big 100 List

Corza Medical Launches Next-Generation Microsurgical Sutures

Corza Medical Appoints Jason Abair as Vice President of Legal & Chief Compliance Officer

Corza Medical Completes Acquisition of TachoSil Manufacturing Operations

Derek Chaves Appointed Chief Financial Officer of Corza Medical

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

Fast Company Magazine Awards Xenco Medical with 2024 Innovation by Design Award for the TrabeculeX Continuum